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Survival dan faktor-faktor prognostik di kalangan pesakit infarksi miokardiun1 akut di 
daerah Kota Bharu~ Kelantan: Kajian retrospektif kohort 2000-2003. 
PENGENALAN 
Penyakit infarksi miokardium akut masih n1erupakan tnasalah kesihatan awmn yang 
utan1a di Malaysia walaupun telah mencapai kemajuan dari segi rawatan dan teknologi 
perubatan. Data setempat berkaitan prognosis penyakit ini boleh men1bekalkan n1akltnnat 
yang penting untuk tindakan pencegahan yang efektif. Objektif kajian ini adalah untuk 
menentukan survival dan tnengenalpasti faktor-faktor prognostik yang men1pengaruhi 
risiko ken1atian pesakit infarksi n1iokardiun1 akut di Kota Bhant. 
METODOLOGI 
Suatu k~jian retrospektif kohort tnelibatkan 368 orang pesakit yang n1engalan1i infarksi 
n1iokardium akut dari daerah Kota Bharu yang ditnasukkan ke dua buah hospital tertiari~ 
Hospital Kota Bharu dan Hospital Universiti Sains Malaysia dari 1 Januari 2000 ke 31 
Disen1ber 2003 telah dijalankan. Perkembangan susulan selmna satu tahun selepas fasa 
pen1ilihan subjek telah dilakukan dari I Januari 2004 ke 31 Disen1ber 2004. Kesenllm 
pesakit yang memenuhi kriteria telah dipilih n1en1asuki kajian ini. Rekod perubatan 
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daripada hospital dan klinik pakar telah disemak oleh seorang penyelidik. Maklun1at yang 
berkenaan dan status survival sehingga 3I Disember 2004 telah direkodkan kedalan1 
borang yang disediakan. Panggilan telefon juga dibuat untuk n1endapatkan n1aklun1at 
tentang survival sesetengah pesakit yang hidup sen1asa discaj tetapi tiada rekod rawatan 
susulan. 
KEPUTUSAN 
Kun1ulatif survival pesakit infarksi miokardium akut di Kota Bharu untuk I hari~ 2 hari~ I 
n1inggu dan I bulan adalah 91.0 (95% confidence interval (CI): 87.6~ 93.5)~ 88.8 (95o/o 
CI: 85.2~ 91.7)~ 86.6 (95% CI: 82.6~ 89.7) dan 83.9 (95% CI: 79.6~ 87.5) peratus. 
Manakala~ kadar survival jangkamasa panjang untuk 6 bulan~ 1 tahun~ 2 tahun. 3 tahun 
dan 4 tahun selepas infarksi miokardiun1 akut adalah 80.7 (95% CI: 76. I. 84.6). 77.5 
(95% CI: 72.6. 81.7). 76.2 (95% CI: 71.2, 80.6), 71.9 (95% CI: 66.0~ 76.9) and 69.2 (95% 
CI: 62.7. 74.8). 
Berdasarkan analisa '"Multivariable Cox Proportional Hazards Regression·· setelah 
n1engan1bilkira lain-lain faktor~ didapati faktor-faktor prognostik bermakna yang 
men1pengaruhi risiko kematian di kalangan pesakit infarksi n1iokardiun1 akut di Kota 
Bhant adalah umur semasa diagnosa (Hazard ratio (HR)=1.03. 95% CI: 1.01. 1.06). 
penyakit diabetes 1nellitus (HR=l.60. 95% CI: 1.03~ 2.46)~ kegagalan ventrikel kiri 
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(HR=2.15, 95% CI: 1.38~ 3.34). rawatan trombolisis (HR=0.48. 95% Cl: 0.3 L 0.73) dan 
tetnpat rawatan yang pet1ama (HR=0.47, 95% CI: 0.24. 0.91 ). 
KESIMPULAN 
Kadar survival dikalangan pesakit infarksi tniokardium akut yang din1asukkan ke hospital 
di Kota Bharu adalah setara dengan negara maju. Kesemua faktor yang didapati 
siknifikan adalah agak serupa dengan keputusan daripada negara lain. kecuali beberapa 
faktor yang penting seperti jantina dan ubat semasa discaj. Tempat rawatan yang pe11an1a 
didapati turut n1empengaruhi risiko kematian infarksi miokardun1 akut di Kota Bhant. 




Survival and prognostic factors of hospitalized acute n1yocardial infarction in district of 
Kota Bharu~ Kelantan: A retrospective cohort study 2000-2003. 
INTRODUCTION 
Acute n1yocardial infarction (AMI) ren1ains a major public health problen1 in Malaysia 
despite advances in medical management and technology. Local prognostic data on AMI 
will provide an essential information for effective preventive measures. The objectives of 
the study were to determine the survival of hospitalized acute n1yocardial infarction 
patients in Kota Bhan1 and identify the prognostic factors that influence the risk of death. 
METHODOLOGY 
A retrospective cohort study was conducted involving 368 hospitalized AMI patients 
from the district of Kota Bharu who were adtnitted in two tet1iary hospital; Hospital Kota 
Bharu and Hospital Universiti Sains Malaysia from I st January 2000 to 3I st Decetnber 
2003. Additional follow up of one year after the recruittnent of the subjects was done 
fron1 I st January 2004 to 3I st Decen1ber 2004. All patients who fulfilled the criteria were 
included in the study. Hospital tnedical records and physician clinic records \Vere 
reviewed by a researcher. The required inforn1ation on variables of interest and patients· 
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survival status until 31st December 2004 was recorded into a data collection forn1. 
Telephone calls were also conducted to obtain the inforn1ation on survival status of son1e 
patients who were discharged alive but loss to follow up. 
RESULTS 
The overall cumulative survival for hospitalized AMI in Kota Bharu were 91.0 (95o/o 
confidence interval (CI): 87.6~ 93.5), 88.8 (95% CI: 85.2., 91.7)~ 86.6 (95o/o CI: 82.6~ 
89.7) and 83.9 (95% CI: 79.6, 87.5) percent for I day, 2 days, I week and I tnonth 
respectively. The long-term survival rate for 6 months, I year, 2 years~ 3 years and 4 
years after AMI were 80.7 (95% CI: 76.1. 84.6), 77.5 (95% CI: 72.6~ 81.7)~ 76.2 (95% 
CI: 71.2. 80.6)~ 71.9 (95% CI: 66.0, 76.9) and 69.2 (95% CI: 62.7~ 74.8) percent 
respectively. 
Based on Cox Proportional Hazards Regression multivariable analysis after adjusting 
other variables, the significant prognostic factors that influenced the risk of death in 
hospitalized acute myocardial infarction patients in Kota Bharu were age at diagnosis 
(HR=I.03. 95% CI: 1.01. 1.06). diabetes n1ellitus (HR=l.60, 95% CI: 1.03~ 2.46), left 
ventricular failure (HR=2.15, 95% CI: 1.38, 3.34 ). thron1bolytic therapy (HR=0.48. 95°/o 
CI: 0.3 L 0.73) and first contact of care (HR=0.47. 95% CI: 0.24. 0.91 ). 
XX 
CONCLUSION 
Survival rate of hospitalized AMI patients in the district of Kota Bharu was con1parable 
with other developed countries. All significant independent prognostic factors identified 
were considerably similar to other countries. except a few itnpot1ant factors such as 
gender and drugs prescribed on discharge. Interestingly. first site contact of n1edical care 
was also identified to significantly influence the risk of death of AMI in Kota Bharu. 
Keyu·ord: myocardial infarction. survival. prognostic factor 
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CHAPTER ONE: INTRODUCTION 
1.1 CARDIOVASCULAR DISEASE 
1.1.1 Global burden of cardiovascular disease 
Cardiovascular disease (CVD) has emerged as the don1inant non con1n1unicable disease 
in n1any parts of the world and become the major cause of n1orbidity and mortality 
\Vorldwide (Khor~ 200I ). At the beginning of the 20th century~ CVD accounted for less 
than I 0 percent of all deaths worldwide. However, at early 21st century~ they accounted 
for at least 15 million deaths or around 30% of the annual total deaths (WHO~ I 998). 
The Global Burden of Disease Study by Murray and Lopez, (1997) had described the 
CVD 1nortality pattern comprehensively. In I 990, CVD accounted for 14.3 million 
deaths, or 28.5% of the world's 50 million deaths. By 2020, CVD will account for nearly 
25 1nil1ion deaths or 36.3% of the estimated 68 milJion deaths worldwide. In contrast, the 
proportion of deaths attributable to cotnmunicable diseases and malnutrition is expected 
to drop fron1 28.4% to I 3.6% over the same period. 
Majority of the CVD deaths now are occurring in developing countries. Twice as n1any 
deaths from CVD now occur in developing countries as in developed countries. During 
the period of 1985 to 1997, death due to circulatory diseases declined fron1 51% to 46% 
of total deaths in the developed countries but increased fron1 16% to 24% in developing 
countries (WHO. 1998). 
Another particular concern is the relatively early age of CVD deaths in developing 
countries con1pared with those in developed countries (WHO. 2003). For exan1ple in 
1990, the proportion of CVD deaths occurring below the age of 70 years was 26.5o/o in the 
developed countries compared with 46.7% in the developing countries (Reddy and 
Yusuf, 1998). 
1.1.2 Contributing factors to global cardiovascular disease 
The underlying determinants of non-comtnunicable disease epiden1ics can be described 
by the evolution of population changes known as epidetniological transition (Gaziano .. 
2001 ). The epidemiological transition has been developed by On1ran where he divided 
the transition into three basic ages: pestilence and famine, receding panden1ics and 
degenerative/ n1an-made diseases. Olshansky and Ault had added a fourth stage so called 
delayed degenerative diseases. The progression of this evolution is closed linked with 
several parallel and interrelated transformations include demographic, econon1ic and 
social transition (Levenson et a/., 2002). The detnographic transition is characterized by 
declining fet1ility and mortality rates. hnprovement of the public health infrastructure .. 
medical care and nutrition. reduced the rates of communicable disease .. n1alnutrition, and 
n1aternal and infant deaths which have led to increase in life expectancy and an aging 
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population. The economic transition is characterized by increasing per capita incon1e 
while the social transition by industrialization and urbanization. The socioeconomic 
developn1ent and lifestyle changes have led to increase in risk factors for CVD 
worldwide. 
In addition. globalization of food production and marketing had contributed to an 
evolution in dietary patterns towards increased consun1ption of higher-fat foods. refined 
carbohydrates and sweets (Ounpuu el al .• 2000 and Reddy and Yusut: 1998). This diet 
pattern. in combination with tobacco use and decreased physical activity. led to 
emergence of population-wide atherosclerosis and widespread distribution of 
cardiovascular diseases (Beaglehole and Yach, 2003 ). 
As the epidemiologic transition is linked to economic. social. and demographic forces. it 
takes place at different rates in different countries around the world (Gaziano, 2001 and 
Levenson et a/., 2002). 
1.2 CORONARY HEART DISEASE 
1.2.1 Worldwide Coronary Heart Disease 
The n1ost important cardiovascular diseases worldwide are coronary heart disease and 
stroke. Coronary heart disease (CHD) is the largest cause of death and the fifth largest in 
tern1s of global disease burden. World wide. there were more deaths fron1 CHI) (7.2 
n1illion) than stroke ( 4.6 million) (WHO. 1998). Murray & Lopez ( 1997) estitnated that 
CHD and stroke would be the first and second causes of death globally hy 2020 ·which 
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accounted for I I. I and 7. 7 n1illion deaths respectively. They also estin1ated that by 2020~ 
CHD will outnumber infectious disease as the world~s nun1ber one cause of death and 
disability. 
The WHO n1onitoring trends and determinants of cardiovascular disease project (WHO 
MONICA) which tnonitored the trend over I 0 years in CHD across 3 7 population in 21 
countries~ demonstrated that CHD event and n1ortality rates vary widely between and 
even within countries. The greatest fall in coronary events rates in men occurred in three 
north European populations leading by North Karelia., Finland. Results from that project 
also highlighted that number of coronary events is the n1ajor determinant of this decline~ 
whereas improved coronary and secondary care were associated with decreased event 
rates (Tundoe-Pedoe el a!.~ 1999). 
Khor. (200 I) had discussed comprehensively the cardiovascular epidetniology in Asia 
Pacific Region. The countries may be ranked into high., intennediate and low CVD 
n1ortality rates according to their proportion of total deaths from all causes. The high 
tnotiality categories include New Zealand~ Australia~ Singapore and sotne Pacific Islands 
and urban areas of China with 30-35% of total death due to CVD. The intennediate 
n1ortality category consists of rural China~ Hong Kong. Japan~ Korea and Malaysia with 
20-30o/o of total deaths from CVD. Countries in the low tnortality category include 
Thailand. Philippina and Indonesia with less than 20% of total deaths. Nevertheless. the 
low mortality in some countries might be due to lack of epidemiological data and 
underreporting of their CVD cases. The high tnortality countries particularly Ne\v 
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Zealand, Australia and Singapore also led in CHD n1ortality (tnore than I 50 deaths per 
I 00 000 population). Countries in East Asia and South East Asia, except Singapore have 
lower CHD tnortality rates of less than I 00 per I 00 000 population (Janus et a!., 1996). 
However~ assessment on trend in recent decades revealed that the high n1ottality 
countries in Asia Pacific have undergone declining event and tnortality rates pattern. 
1.2.2 Coronary Heart Disease in Malaysia 
The epidemiology of CVD particularly CHD in Malaysia was poorly known due to n1any 
reasons which include problen1 in standard diagnosis, coding and reporting~ poor 
surveillance, poor statistical support and lack in good epidetniological studies (Lo~ I988). 
It is likely that CVD death cases in Malaysia may be underestimated, as less than half of 
the total deaths were tnedically certified and exan1ined (Khot\ 200 I). 
Based on available data, cardiovascular disease had risen markedly during the last 40 
years in Malaysia. Since the early I 970's, cardiovascular diseases have been the leading 
cause of mortality in Malaysia among medically certified and inspected cases. Coronary 
heart disease had emerged as the n1ost in1portant cardiovascular disease. The increase 
n1ay be partly contributed by in1proved method of diagnosis and reporting (Khor. 1994 ). 
However. this could indicate an actual increase in the occurrence of disease as a result of 
in1prove socioeconomic status and changing lifestyle of Malaysian population 
(.Jeyan1alar. 1991 ). 
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Cardiovascular disease ranked third in the 1950's but gradually took the first position in 
I 970 and continued to do so in I 989 with an increase of I 6.5 times fron1 prevalence of 
1.8% in I 950 to 29 .6o/o in 1989. On the other hand. infectious disease which was ranked 
first in the I 950s had fallen fourth position in I 989. Similarly, the cardiovascular disease 
n1ortality had increased from 9.2% in I 965 to 29.6o/o in I 989 while n1ortality fron1 non 
cardiovascular diseases dropped from 90.8% in 1965 to 70.4% in 1989 (Khoo. 1991 ). 
In I 955, .. Heart Disease' was not even listed as one of the I 0 principal causes of 
n1edically certified death but between 1955 and 1965 it rose to second position and since 
1980. has becon1e the leading cause of death in Malaysia (Lo. 1988). The proportion of 
CHD deaths out of total mortality causes rose from 3% in 1965 to I 1% in I 991 (Khoo, 
I99I and Khor. I994 ). At present, 'Heart disease and diseases of puln1onary circulation' 
still ranked in the first position of the 10 principal causes of death in medically certified 
death till year 2001. Its proportion out of total mortality generally sustained at about I6o/o 
fron1 I 995 to 200 I. In terms of trend, the mortality rate based on number of deaths in 
government hospital under 'ischemic heart disease' increased fron1 9.85 to I 0.58 per 
I 00,000 population during the same period of time (lnfonnation and Docun1entation 
Systen1 Unit, Ministry of Health Malaysia. 2002). 
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1.3 ACUTE MYOCARDIAL INFARCTION 
Coronary heart disease or ischaemic heart disease (includes acute rnyocardial infarction. 
angina pectoris and sudden coronary death) is the single most important cause of death 
among hospitalized patient worldwide (WHO. 2002). Acute myocardial infarction (AMI) 
or heart attack is the commonest coronary heart disease with serious consequences in 
rnortality. morbidity and cost to nation and society (Boersma eta!., 2003). 
Over the past 30 years. the trend of AMI mortality was declining and the short-term 
prognosis of patients with acute myocardial infarction (AMI) have shown a steady 
irnprovement in the industrialized nations (Sytkowski et a!., 1996. Tundoe-Pedoe et a! .. 
1999 and Rosamond et al.. 1998). Additionally, recent studies reported that the long-term 
AMI prognosis were also tend to improve (Abrahamsson et al.. 1998. Capewell et a/ .. 
2000 and Mahon el a/., 1994). The improved prognosis was attributed rnainly to changing 
risk factor profiles and substantially due to improvement in treatrnent (Alpert. 1999). 
Sorne of these studies also had documented the main determinants of AMI death 
(Stevenson et al., 1993, Abrahamsson el a/., 1998 and Marcos eta/., 1998). 
Generally. the improvement in management of patients with acute myocardial infarction 
includes the introduction of reperfusion therapy in the 1980's and developrnent of 
catheter based interventions in the 1990's (Boersma el a/., 2003 and Berger and Orford. 
2004 ). In addition, chronic drug treatment has contributed to irnprove long-term 
prognosis of the survived patients (Boersrna eta! .. 2003 ). 
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Despite these advances~ myocardial infarction remains a major public health problen1 
both in developed and developing countries. For exatnple~ although CHD ITIOI1ality has 
declined in United States, it has remained the leading cause of death in that country and 
acute 1nyocardial infarction contributed the greatest rate. The estimated number of 
1nyocardial infarction in United States is 565,000 new attacks and 300~000 recurrent 
attack annually (American Heart Association~ 2005). 
In Malaysia, Acute Coronary Syndromes represent a large number of hospitalizations 
with 33.,623 patients admissions in year 2000 (Ministry of Health~ Malaysia~ 2002). 
However, data for incidence and survival of AMI in Malaysia is sparse. Even developed 
countries including the United States have limited data on the incidence of CHD~ since it 
is very difficult and expensive to collect detailed morbidity and n1ortality figures over an 
extended period of tin1e. Nevertheless, in Singapore~ where all MI in the country are 
systen1atically entered in MI registry, the incidence of MI was 104.3 per 100.,000 in 1988 
and show declining pattern to 82.6 per 1 00~000 population in I 997 (Tan et a/., 2002). 
1.4 IMPORTANCE AND RATIONALE OF THIS STUDY 
Coronary heart disease is a significant cause of tnorbidity and n1ortality in Malaysia in 
recent decades. Among them, acute myocardial infarction is the con1n1onest cause of 
death. There is a need to take corrective action before the incidence and tnortality of 
coronary heat1 disease in this country continue to increase rapidly during the next 
decades. Hence., research on this major disease n1erit continued attention. 
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Furthermore. the WHO MONICA project revealed coronary heart disease mortality rates 
vary \videly between and even within countries (Tundoe-Pedoe et al., 1999). It was also 
different when observed even in the same urban areas of one country in different racial or 
socioeconornic status. This strengthened the need of assessing the survival status of local 
co1nmunities and come up with local data that provide useful information for local 
effective preventive measures. 
Despite advances in medical rnanage1nents, myocardial infarction re1nains an i1nportant 
public health proble1n worldwide. Although the in-hospital mortality is reducing. 
unhealthy lifestyle resulted in increasing incidence of AMI especially in developing 
countries. The ageing comrnunity, rising prevalence of diabetes and hypertension and the 
i1nproved survival of acute coronary syndromes have resulted in growing population of 
patients with chronic conditions (Boersma et al., 2003). Further research on prognosis of 
AMI is warranted because AMI is inevitable in Malaysia which also experiences 
increasing number of patients with chronic conditions. 
Studies on survival and prognostic factors of AMI are important and rnerit further 
assessment especially in Malaysia where such data are lacking. Assessment on AMI 
survival status may provide useful infonnation on our underlying cardiovascular 
preventive action and 1nedical care. Additionally, identification of local prognostic 
factors may impart more knowledge on relevant areas to improve AMI prognosis in our 
comrnunity. 
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CHAPTER TWO : 
OBJECTIVES, RESEARCH QUESTIONS & HYPOTHESIS 
2.1 OBJECTIVES 
2.1. 1 General objective 
To determine the survival of hospitalized acute myocardial infarction patients in Kota 
Bharu and identify the prognostic factors that influence the risk of death 
2.1.2 Specific objectives 
I. To determine the overall survival probabilities of hospitalized acute myocardial 
infarction patients in Kota Bharu 
2. To detern1ine the survival probabilities of hospitalized acute n1yocardial infarction 
patients in Kota Bharu by specific subgroups in tern1s of detnographic. co-n1orbidity. 
adrnission care and clinical characteristics 
3. To identify the prognostic factors that influence the risk of death in hospitalized acute 
n1yocardial infarction patients in Kota Bharu 
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2.2 RESEARCH QUESTIONS 
I. What are the overall survival probabilities of hospitalized acute n1yocardial infarction 
patients in Kota Bharu? 
2. Are the survival probabilities of hospitalized acute myocardial infarction patients in 
Kota Bharu differ by den1ographic~ co-morbidity~ adn1ission care and clinical 
characteristics? 
3. What are the prognostic factors that influence the risk of death in hospitalized acute 
n1yocardial infarction patients in Kota Bharu? 
2.3 RESEARCH HYPOTHESIS 
1. Den1ographic characteristics (age~ gender and race)~ co-n1orbidity characteristics 
(having diabetes mellitus~ hypetiension~ previous coronary atiery disease or stroke)~ 
admission care characteristics (time of symptom to adn1ission, first n1edical contact of 
care, admitting hospitaL ward of admission and year of admission) and clinical 
characteristics (Q wave. having left ventricular failure. given thrombolytic therapy. 
aspirin. beta-blocker~ ACE inhibitor. statin and interventions conducted) are the 
prognostic factors that influence the risk of death in hospitalized acute n1yocardial 
infarction patients in Kota Bhan1. 
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2.4 OPERATIONAL DEFINITIONS 
Survival probability is defined as the probability that an individual survives longer than t 
(survival time). Statistically .. it is also known as cumulative survival rate (Lee .. 1992). 
Prognosis refers to the possible outcomes of a disease and the frequency with which they 
can be expected to occur. Meanwhile. prognostic factors are the characteristics of a 
particular patient that predict the patient's eventual outcome (Laupacis el a/., 1994 ). 
Hospitalization refers to patient who was admitted or warded to either coronary care unit 
(CCU). cardiac rehabilitation ward (CRW) or general medical ward of Hospital Kota 
Bharu (HKB) and Hospital Universiti Sains Malaysia (HUSM). 
AMI can be defined from a number of different perspectives related to clinical. 
electrocardiographic (ECG), biochemical and pathologic characteristics (Alpert and 
Thygesen et a/., 2000). AMI used in this present study was defined by a cotnbination of 
two out of three criteria as outlined by the WHO (Ministry of Health. Malaysia. 2001 )~ 
l.A typical clinical history of ischen1ic type of chest discomfort. 
2.A raised and fall concentration of serum cardiac markers (include creatine kinase (CK) 
or preferably creatine kinase tnyocardial band (CKMB) enzyn1e). 
3 .A typical serial ECG changes (development of ST elevation (> 0.1 m V in standard lin1b 
leads or> 0.2 n1Y in two or more precordial leads) or pathological Q wave). 
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CHAPTER THREE: LITERATURE REVIEW 
3.1 INTRODUCTION TO ACUTE MYOCARDIAL INFARCTION 
3.1.1 Definition and concept 
The term myocardial infarction (MI) reflects ischemic necrosis of cardiac n1yocytes due 
to prolonged inadequate blood supply produced by an acute occlusion of the coronary 
artery (Ministry of Health, Malaysia, 2001 ). The necrosis and loss of functional 
n1yocardiun1 will result in ventricular dysfunction. Further reduce in left ventricular 
function can affect patienfs quality of life and causes pretnature death (Boersn1a et a/ .. 
2003). 
Clinically. early administration of reperfusion therapy will allow more rapid restoration 
of coronary blood flow. Patients with MI that treated most rapidly have a lower n1ortality 
and reduce infarct size in the survivors (Berger and Orford, 2004 ). Severity of left 
ventricular dysfunction after discharge would also detern1ine MI death after discharge 
(Ali eta/ .. I 99). Apart from that, en1erging evidences have shown that the prognosis after 
Ml were also associated by various other factors such as age, concurrent n1edical illnesses 
and partly socioeconon1ic reasons (Donahue et a!., 1993. Miettinen et a/., 1998. Barakat 
eta/., 1999, Hetningway and Marmot, 1999 and Crowley, 2003). 
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3.1.2 Pathophysiology 
Atherosclerosis underlies most CHD. The development and progression of atherosclerotic 
lesions is a chronic inflammatory process (Mulvihill and Foley~ 2002). Risk factors such 
as raised plasn1a low density lipoprotein cholesteroL decreased high density lipoprotein 
cholesterol, smoking~ high blood pressure and increased glucose concentration stitnulate 
and activate the inflammatory cells including monocytes and lymphocytes via several 
pathways (Boerstna et a!.~ 2003 ). These cells are rich in cytokines and growth factors. 
which could induce and amplify inflamtnation in the endotheliutn (Mulvihill and Foley. 
2002). Consequently, continuing inflammatory process results in atherosclerotic lesion 
that composed of a core of lipid and necrotic tissue., covered by fibrous capsule (Davies 
and Bashir~ 200 I). 
In the advanced stages of disease process, atherosclerotic plaques develop. 
Atherosclerotic plaques that rich in foam cells (lipid laden n1acrophages) are susceptible 
to sudden plaque rupture and hemon·hage into the vessel wall. Intraluminal throtnbus 
forn1ed when fissuring or disruption of the atherosclerotic plaques took place. This 
throtnbus can superimpose on the ruptured plaque resulting in sudden pat1ial or total 
occlusion of the coronary artery (Davies~ 2000 and Davies and Bashir~ 2001 ). 
Transient partial occlusion~ local vasoconstriction and platelet aggregates etnbolisation 
are several potential mechanisms that result in intermittent acute n1yocardial ischaen1ic 
syndron1e of angina pectoris (Davies~ 2000). However. irreversible dan1age to the 
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myocardium might occur if a coronary occlusion persists for longer than 15 n1inutes. 
Consequently. continuous occlusion of at least 4 to 6 hours or longer kills the affected 
n1yocytes resulting in n1yocardial infarction (Davies, 2000 and Davies and Bashir. 2001 ). 
3.1.3 Correlations benveen arterial pathology and clinical presentation 
Angina pectoris is chest pain due to tnyocardial ischemia. Stable angina is predictable 
chest pain on exertion or under mental or emotional stress whereas unstable angina is 
chest pain that is unexpected and usually occurs at rest. Chest pain in acute myocardial 
infarction is due to prolonged ischemia that results in myocardial cell death or necrosis. 
(An1erican Heart Association, 2005). 
The pathological sequelae and progression of atherosclerosis dictates the clinical 
presentation. During the natural course of atherosclerosis and throtnbosis. acute 
tnyocardial ischemia can be presented as a range of ische1nic cardiac tnanifestations 
which is known as acute coronary syndron1e (ACS). 
Although imprecise, the correlations between events in the coronary arterial lun1en and 
ECG fonn the basis of disease classification and managen1ent decision (Davies and 
Bashir, 2001 ). As such, ACS covers the spectrutn of clinical conditions that ranges fron1 
unstable angina to non ST elevated myocardial infarction and ST elevated n1yocardial 
infarction which result frotn a common underlying pathophysiological mechanisn1 
(Boersma et a! .. 2003 and Davies & Bashir. 200 I). 
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Recently. ACS has evolved as a useful operational terminology to describe the clinical 
syn1ptoms that is con1patible with progress of acute tnyocardial ischen1ia at tin1e of 
presentation (Ministry of Health. Malaysia. 2002). This new tenn is increasingly used to 
describe patient who present with acute myocardial infarction or unstable angina 
(American Heart Association. 2005). 
Figure 3.1 shows clinical classifications of ACS. Most patients who have ST-segn1ent 
elevation will ultin1ately develop a Q-wave acute myocardial infarction. Patients who 
have ischen1ic discomfort without an ST -segment elevation are having either unstable 
angina (UA). or a non-ST-segment elevation myocardial infarction (NSTEMI) that 
usually leads to a non-Q-wave myocardial infarction. The distinction between patients 
with UA and NSTEMI is ultimately made based on the presence or absence of a cardiac 
n1arker in blood, most comn1only troponin I, troponin T or creatinine kinase myocardial 
nabd (CKMB). The diagnosis of NSTEMI is established if a cardiac n1arker is detected 
(Ministry of Health. Malaysia. 2002). 
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NSTEMI STEM I 
Unstable Angina Non Q wave MI Q wave MI 
Myocardial i11[arction 
ST = ST segment of ECG trac ing; NSTEM I = non-ST elevation myocard ial inf'arction: 
NQM I = non-Q wave myocard ial infarction; Q wave MI = Q wave myocardial infarction. 
Source : (C lini ca l Practice Guide lines on Unstable Angina and Non ST elevated M yocardial i nfarct ion. 
Ministry of Health. Malaysia. 2002). 
Figm·c 3.1 Clinical classification of acute coronaa·y syndromes 
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3.1.4 Diagnosis 
According to the World Health Organization, the diagnosis of acute myocardial infarction 
is based on the presence of at least two of the following three criteria: 
A.A clinical history of ischemic type chest discomfort. 
B.An evolutionary changes on serially obtained ECG tracings. 
C.A rise and fall in serum cardiac n1arkers. 
(Ministry of Health, Malaysia, 2001) 
3.1.4 (a) History 
Chest pain due to acute myocardial infarction usually occurs at retrosternal area which 
lasted at least 20 minutes. The pain is usually central or in the left chest and may radiate 
to the jaw. neck, ann shoulder or back but occasionally may occur in epigastric region. It 
n1ay be of crushing. pressing or burning in nature and usually not sharp or highly 
localized (Ministry of Health, Malaysia, 2001 ). 
Diaphoresis, nausea. vomiting or light-headedness may be noted in association with chest 
discotnfoti or they may occur in the absence of chest syn1ptoms although such pattern is 
atypical. Nevertheless, diabetics, elderly and females cotnmonly present with atypical 
chest pain and dyspnea (Ministry of Health, Malaysia. 2001 and Berger and Oxford, 
2004). 
18 
3 .I.4 (b) Electrocardiographic changes 
The evolutionary ECG changes of AMI include hyperacute changes of a tall peaked T 
wave .. ST segment elevation followed by the formation of Q wave .. return of the ST 
segn1ent to isoelectric and T wave inversion. The presence of new onset bundle branch 
block in a patient with typical chest pain n1ight indicate an infarct (Ministry of Health. 
Malaysia .. 200 I). 
ECG findings were related with corresponding coronary pathophysiology. ST segn1ent 
changes indicate underlying myocardial ischen1ia while Q waves provide evidence of the 
loss of electrically functioning cardiac tissue (Berger and Orford .. 2004 ). ST elevation 
results from complete obstruction to coronary flow for more than one hour (Davies and 
Bashir. 200 I). Thus .. ECG finding is a valuable tool both in confirn1ing the diagnosis of 
acute n1yocardial infarction and selecting appropriate therapy for the patient (Berger and 
()rford, 2004 ). 
3.I.4 (c) Serum cardiac markers 
Myocyte ischemia and necrosis results in damage to the cells and subsequently release of 
intracellular enzymes into the circulating blood which permit their detection as cardiac 
n1arkers by blood test. The cardiac markers consist of creatine kinase n1yocardial hand 
(CKMB). cardiac troponins .. creatine kinase (CK). aspartate an1ino transferase. lactate 
dehydrogenase and myoglobin. Elevated values for cardiac n1arkers should he recorded 
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on two consecutive blood samples to diagnose AMI (Ministry of Health~ Malaysia. 
2001 ). Cardiac troponins and CKMB are the n1ost specific cardiac n1arkers. CKMB takes 
at least 3 hours after a profound ischemia to rise above the normal level. Values for 
CKMB should rise and fall. In contrast. cardiac troponins levels rise soon after 
1nyocardial injury and a single raised Troponin T or I is sufficient to indicate n1yocardial 
necrosis (Berger and Orford, 2004). 
3. I .4 (d) Other diagnostic modalities 
Imaging techniques such as echocardiography and radionuclide techniques may be useful 
in identifying patients with n1yocardial infarction in the en1ergency departn1ent (Berger 
and Orford, 2004 ). These technologic advances have high sensitivity to detect very sn1all 
infarcts that individual who was formerly diagnosed as having severe. stable or unstable 
angina pectoris might be diagnosed today as having had a sn1all MI (Alpert and 
Thygesen. 2000). 
Echocardiography is used to visualize regional wall motion abnormalities that occur 
within seconds of coronary occlusion and well before myocyte necrosis. Sitnilarly. 
perfusion ilnaging with both thallium and sestan1ibi which is used to visualize cardiac 
tissue perfusion has been reported to be both sensitive and specific in the evaluation of 
patients in whom the diagnosis is uncertain. As such. both echocardiographic and 
radionuclide techniques are not required in patients with symptoms and ECG that 
evidence typical acute 1nyocardiaJ infarction (Berger and Orford. 2004 ). 
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1' 
The European Society of Cardiology (ESC) and the Atnerican College of Cardiology 
(ACC) have recently revised the definition of myocardial infarction. This new definition 
as shown in Table 3.1 integrated highly sensitive and specific serologic n1arkers and 
precise in1aging techniques. 
The updated definition more accurately reflects the patient's clinical course and current 
scientific thinking. Application of WHO definition in clinical practice results in several 
patients erroneously diagnosed with non-n1yocardial infarction where actually 
irreversible myocardial damage has occurred. In addition, a sensitive detection for 
cardiac injury is more appropriate for purposes of risk stratification and subsequent 
treatn1ent for MI (Boersma eta!., 2003). 
However, at present, the widespread availability and standard application of the n1easures 
generating these criteria is probably limited due to its implication on individual patient. 
society and health resources. Additionally, the application of new and n1ore sensitive 
criteria for AMI will result in the rise of recorded MI incidence and fall in the case 
fatality rate. Therefore, for the purpose of epidemiological monitoring. established 
definitions (example by WHO MONICA project) should be retained for comparison with 
previously collected data. At the same time, current biomarker-based definition of AMI 
should be applied concurrently where possible to compare with research that en1ploy 
n1ore recent standard for defining AMI (Alpert and Thygesen. 2000). 
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Table 3.1: Clinical Definitions of Myocardial Infarction as determined by the Joint 
European Society of Cardiology/ American College of Cardiology Committee 
Criteria for acute, evolving or recent M I 
Either one of the following criteria satisfies the diagnosis for an acute. evolving or recent Ml: 
• Typical rise and gradual fall (Troponin) or more rapid rise and fall (CK-MB) of biochemical 
markers of myocardial necrosis with at least one of the following: 
./ ischemic symptoms~ 
./ development of pathologic Q waves on the ECG; 
./ ECG changes indicative of ischemia (ST segment elevation or depression)~ or 
./ coronary artery intervention (e.g .• coronary angioplasty). 
• Pathologic findings of an acute MI. 
Criteria for established M I 
Any one of the following criteria satisfies the diagnosis for established Ml: 
• Development of new pathologic Q waves on serial ECGs. The patient may or may not 
remember previous symptoms. Biochemical markers of myocardial necrosis may have 
normalized. depending on the length of time that has passed since the infarct developed. 
• Pathologic findings of a healed or healing MI. 
Source : (Alpert and Thygesen. 2000) 
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3.1.5 Treatment 
The goal in the treatment of AMI is to improve the blood flow through the occluded 
coronary artery rapidly as to prevent injury to the myocardiun1. In addition~ treattnent 
aims to provide lasting restoration of coronary blood circulation. 
Early n1anagement of AMI involves oral asptnn~ oxygen administration~ pain relief 
usually by intravenous morphine, stabilization of haemodynatnics and assessn1ent for 
reperfusion. The choices of reperfusion therapy are either thron1bolytic therapy or 
primary I direct Percutaneous Transluminal Coronary Angioplasty (PTCA). Presently~ the 
thrombolytic agents that available locally are Streptokinase and Tissue Plasn1inogen 
Activator (tP A). Although studies have shown that tPA ts moderately superior to 
Streptokinase, the latter is more favorable because it ts less expensive. Thus~ 
Streptokinase is the most widely used agent locally. However, as a reperfusion strategy. 
pritnary PTCA has been shown to be more effective than thrombolytic therapy in 
achieving and sustaining a patent-infarct related artery. The availability of primary PTCA 
is however limited to only few centers in the country. It should be considered in 
experienced centers and the door to balloon tin1e of less than 60-90 n1inutes (Berger and 
Orford. 2004 ). 
Other adjunctive pharmacotherapy includes aspirin, beta blockers and ACE inhibitor 
(Ministry of Health~ Malaysia~ 200 I). 
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3.1.6 Complication 
Complications of AMI include arrhythmias, left ventricular dysfunction and others. 
Arrhythmias can be divided into tachyarrhythmias and bradyarrhythn1ias. The clinical 
spectrum of left ventricular dysfunction varies from asymptomatic to heart failure and 
cardiogenic shock (Ministry of Health, Malaysia, 2001 ). Chest pain post-AMI n1ay be 
due to reinfarction, ischemia or pericarditis. Other identified complication is left 
ventricular thron1bus which can lead to stroke (Berger and Orford, 2004). 
3.1. 7 Risk stratification post acute myocardial infarction 
Risk stratification serves to identify patient who is likely to develop complication and 
take appropriate treatment strategies to prevent them. The high risk patients should be 
considered for early coronary angiography. Low risk patients should be prescribed with 
optin1al tnedication and may be allowed to return to their former activities. 
3.1.8 Secondary and tertiary prevention 
Secondary prevention includes risk factors modifications and phannacotherapy. 
Behaviour n1odifications such as cessation of smoking, healthy diet and increase physical 
activity are highly advised. Hypertension, diabetes n1ellitus and hypercholesterolen1ia 
should be treated optimally. The cardiac rehabilitation progran1n1e helps the AMI 
survivors to establish a healthier lifestyle (Berger and Orford. 2004 ). 
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